These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3929594)

  • 61. [Treatment of duodenal ulcer with cimetidine. Double blind study].
    Chantres MT; Rebollar JL; Rosso C; Ballarin M; Pérez Oteyza C; García Paredes J; Gilsanz V
    Rev Clin Esp; 1980 Sep; 158(5):209-13. PubMed ID: 7001577
    [No Abstract]   [Full Text] [Related]  

  • 62. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
    Petrillo M; Bianchi Porro G
    Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
    Laine L; Suchower L; Frantz J; Connors A; Neil G
    Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical assessment of trithiozine for duodenal ulcer.
    Rybicka J; Gibiński K
    Acta Med Pol; 1980; 21(2):159-64. PubMed ID: 7211464
    [No Abstract]   [Full Text] [Related]  

  • 65. Double-blind placebo-controlled evaluation of one year therapy with sucralfate in healed duodenal ulcer.
    Moshal MG; Spitaels JM; Manion GL
    Scand J Gastroenterol Suppl; 1983; 83():57-9. PubMed ID: 6356322
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
    Giacosa A; Cheli R; Molinari F; Parodi MC
    Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protocol design for recent duodenal ulcer maintenance trials.
    Eshelman FN; Holland CE
    Am J Med; 1984 Nov; 77(5B):30-2. PubMed ID: 6095658
    [TBL] [Abstract][Full Text] [Related]  

  • 68. H-2receptor antagonist (cimetidine) in the treatment of chronic duodenal ulcer and its effect on gastric secretions.
    Guha Mazumdar DN; Dutta S; Ghose AK; Pal S; Ghose KK
    J Assoc Physicians India; 1981 Dec; 29(12):999-1006. PubMed ID: 6754691
    [No Abstract]   [Full Text] [Related]  

  • 69. [Acute treatment of duodenal ulcer. Results of an open multicenter study with famotidine nocte].
    Schönekäs H
    Fortschr Med; 1988 May; 106(14):304-6. PubMed ID: 3042560
    [No Abstract]   [Full Text] [Related]  

  • 70. New drugs in gastroenterology.
    Friedman G
    Mt Sinai J Med; 1985 Jun; 52(6):484-9. PubMed ID: 3875031
    [No Abstract]   [Full Text] [Related]  

  • 71. Cytoprotective dose of prostaglandins.
    Wilson DE
    Gastroenterology; 1987 Aug; 93(2):434. PubMed ID: 3596177
    [No Abstract]   [Full Text] [Related]  

  • 72. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Lauritsen K; Rask-Madsen J
    Arch Intern Med; 1990 Mar; 150(3):695. PubMed ID: 2310294
    [No Abstract]   [Full Text] [Related]  

  • 73. Misoprostol: is it safety or a lack of understanding that prevents its more frequent usage?
    Blikslager AT
    Equine Vet J; 2013 Jan; 45(1):8. PubMed ID: 23231384
    [No Abstract]   [Full Text] [Related]  

  • 74. Drugs recently released in Belgium. Enprostil--Selegiline.
    Harvengt C
    Acta Clin Belg; 1989; 44(4):284-6. PubMed ID: 2515703
    [No Abstract]   [Full Text] [Related]  

  • 75. Controlled trial of arbaprostil in bleeding peptic ulcer.
    Lauritsen K; Laursen LS; Havelund T; Bytzer P; Rask-Madsen J
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1093. PubMed ID: 3931810
    [No Abstract]   [Full Text] [Related]  

  • 76. Anti-NGF painkillers back on track?
    Holmes D
    Nat Rev Drug Discov; 2012 Apr; 11(5):337-8. PubMed ID: 22543456
    [No Abstract]   [Full Text] [Related]  

  • 77. FDA Arthritis Advisory Committee meeting: guidelines for clinical evaluation of therapies for scleroderma.
    Paulus HE
    Arthritis Rheum; 1992 Jul; 35(7):835-6. PubMed ID: 1622422
    [No Abstract]   [Full Text] [Related]  

  • 78. FDA guidance on topical corticosteroid bioequivalency: Summary of the September 1994 Meeting of the Generic Drugs Advisory Committee with Dermatologic Drugs Advisory Committee Representation.
    Schrode KB
    Skin Res Technol; 1995 Feb; 1(1):47-8. PubMed ID: 27328223
    [No Abstract]   [Full Text] [Related]  

  • 79. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.
    Barradell LB; Whittington R; Benfield P
    Pharmacoeconomics; 1993 Feb; 3(2):140-71. PubMed ID: 10146962
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prostaglandins in peptic ulcer disease. An overview of current status and future directions.
    Sontag SJ
    Drugs; 1986 Nov; 32(5):445-57. PubMed ID: 3792228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.